These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30335080)

  • 1. [Non-motor disorders in patients with muscular dystonia].
    Salouchina NI; Nodel MR; Tolmacheva VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):98-105. PubMed ID: 30335080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep in patients with primary dystonia: A systematic review on the state of research and perspectives.
    Hertenstein E; Tang NK; Bernstein CJ; Nissen C; Underwood MR; Sandhu HK
    Sleep Med Rev; 2016 Apr; 26():95-107. PubMed ID: 26164369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence and Correlation of Non-motor Symptoms in Adult Patients with Idiopathic Focal or Segmental Dystonia.
    Novaretti N; Cunha ALN; Bezerra TC; Pena Pereira MA; de Oliveira DS; Macruz Brito MMC; Pimentel AV; Brozinga TR; Foss MP; Tumas V
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():596. PubMed ID: 30783550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of fatigue and sleep disturbances in dystonia.
    Wagle Shukla A; Brown R; Heese K; Jones J; Rodriguez RL; Malaty IM; Okun MS; Kluger BM
    Int J Neurosci; 2016 Oct; 126(10):928-35. PubMed ID: 26289935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-motor symptoms in patients with adult-onset focal dystonia: Sensory and psychiatric disturbances.
    Conte A; Berardelli I; Ferrazzano G; Pasquini M; Berardelli A; Fabbrini G
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S111-4. PubMed ID: 26360238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric disorders in adult-onset focal dystonia: a case-control study.
    Fabbrini G; Berardelli I; Moretti G; Pasquini M; Bloise M; Colosimo C; Biondi M; Berardelli A
    Mov Disord; 2010 Mar; 25(4):459-65. PubMed ID: 20108377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystonic frowning without blepharospasm.
    Hirota N; Hirota M; Mezaki T
    Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm.
    Weiss D; Hieber L; Sturm J; Börtlein A; Buchthal J; Dippon C; Arnold G; Wächter T
    Clin Neurol Neurosurg; 2018 Sep; 172():130-133. PubMed ID: 29990961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive symptoms in primary focal dystonia: a controlled study.
    Barahona-Corrêa B; Bugalho P; Guimarães J; Xavier M
    Mov Disord; 2011 Oct; 26(12):2274-8. PubMed ID: 21830232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Flexibility in Primary Dystonia.
    Lange F; Seer C; Dengler R; Dressler D; Kopp B
    J Int Neuropsychol Soc; 2016 Jul; 22(6):662-70. PubMed ID: 27333537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes.
    Timmers ER; Smit M; Kuiper A; Bartels AL; van der Veen S; van der Stouwe AMM; Santens P; Bergmans B; Tijssen MAJ
    Parkinsonism Relat Disord; 2019 Dec; 69():85-90. PubMed ID: 31706131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Botulinum Toxin for Treatment of the Dystonias.
    Berardelli A; Conte A
    Handb Exp Pharmacol; 2021; 263():107-126. PubMed ID: 31820178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications.
    Stamelou M; Edwards MJ; Hallett M; Bhatia KP
    Brain; 2012 Jun; 135(Pt 6):1668-81. PubMed ID: 21933808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.